Close Menu

NEW YORK – Revolution Medicines today said that it has raised $100 million in a Series C financing round to support its pipeline of oncology drugs focused on specific pathways.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.